XDNA SEC Filings — Kelly CRISPR & Gene Editing Technology ETF

XDNA Prospectus (485BPOS / 497)

Objective, strategy, fees and risks. 2 filings on SEC EDGAR.

• Filed Dec 22, 2022 · 485BPOS
• Filed Dec 23, 2021 · 497

XDNA Portfolio holdings (N-PORT)

Full holdings and monthly flows, filed quarterly. 8 filings on SEC EDGAR.

• Filed Jan 24, 2024
• Filed Oct 27, 2023
• Filed Jul 20, 2023
• Filed Apr 24, 2023
• Filed Jan 23, 2023
• Filed Oct 28, 2022
• Filed Jul 25, 2022
• Filed Apr 25, 2022

XDNA Annual census (N-CEN)

Service providers, brokerage and operations. 3 filings on SEC EDGAR.

• Filed Nov 13, 2024
• Filed Nov 14, 2023
• Filed Nov 14, 2022

Data Sources

ABC INVEST compiles this page from public filings made to the U.S. Securities and Exchange Commission (SEC) through EDGAR: portfolio holdings and monthly cashflows from Form N-PORT, expenses and returns from fund prospectuses (Form 485BPOS) and the SEC DERA Risk/Return Summary data sets, and annual data from Form N-CEN.

For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.